Mitotane

In some countries, this medicine may only be approved for veterinary use.

In the US, Mitotane (mitotane systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Adrenal Cortical Carcinoma.

US matches:

• Mitotane

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XX23

CAS registry number (Chemical Abstracts Service)

0000053-19-0

Chemical Formula

C14-H10-Cl4

Molecular Weight

320

Therapeutic Category

Antineoplastic agent

Chemical Name

Benzene, 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]-

Foreign Names

• Mitotanum (Latin)
• Mitotan (German)
• Mitotane (French)
• Mitotano (Spanish)

Generic Names

• Mitotane (OS: USAN, JAN)
• CB 313 (IS)
• NSC 38721 (IS)
• Piprine-DDD, O- (IS)
• Mitotane (PH: USP 32)

Brand Names

• Lisodren
  Bristol-Myers Squibb, Brazil



• Lysodren
  Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Ferlito, Italy; Globopharm, Switzerland; HRA, Denmark; HRA, Spain; HRA, Finland; HRA, France; HRA, Luxembourg; HRA, Netherlands; HRA, Poland; HRA Pharma, Belgium; HRA Pharma, Germany; HRA Pharma, United Kingdom; Lab.HRA Pharma, Greece; Laboratoire HRA, Slovenia; Laboratoire HRA Pharma, Austria



• Lysodren (veterinary use)
  Labor Laupeneck, Switzerland



• Mitotane (veterinary use)
  IDIS, United Kingdom



• Opeprim
  Yakult, Japan

International Drug Name Search

Glossary

IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.